-
Story /Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.
-
Story /Working with a nonprofit, Novartis is helping train healthcare workers to diagnose and treat chronic ailments such as diabetes.
-
Story /Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.
-
Story /Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
-
Story /Zebrafish imaging sheds light on human neurological conditions.
-
Story /New head of oncology research hopes to build on recent advances, explore new therapeutic approaches and beat certain cancers for good.
-
Story /The most lethal strain could be eliminated by 2030, but major hurdles remain.
-
Featured News /
The Co-Creating Impact Summit happening on December 9th, 2020, will gather experts inside and outside of Novartis to continue our work of improving our impact on the society and the planet.
-
Featured News /
EPIS participants call for all stakeholders to ensure the patient voice is at the heart of the development of digital health solutions
-
Featured News /
A new AI-enabled disease management tool in China aims to improve the lives of millions of patients with heart failure.
Pagination
- ‹ Previous page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- …
- 149
- › Next page